Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 18;12(2):523.
doi: 10.3390/diagnostics12020523.

Diagnostic Performance of Point Shear Wave Elastography (pSWE) Using Acoustic Radiation Force Impulse (ARFI) Technology in Mesenteric Masses: A Feasibility Study

Affiliations

Diagnostic Performance of Point Shear Wave Elastography (pSWE) Using Acoustic Radiation Force Impulse (ARFI) Technology in Mesenteric Masses: A Feasibility Study

Amjad Alhyari et al. Diagnostics (Basel). .

Abstract

Purpose: To evaluate the diagnostic performance of ultrasound point shear wave elastography (pSWE) using acoustic radiation force impulse (ARFI) technology in different benign and malignant mesenteric masses (MMs).

Methods: A total of 69 patients with MMs diagnosed from September 2018 to November 2021 were included retrospectively in the study. The inclusion criteria were (1) an MM over 1 cm; (2) valid ARFI measurements; and (3) confirmation of the diagnosis of an MM by histological examination and/or clinical and radiological follow-up. To examine the mean ARFI velocities (MAVs) for potential cut-off values between benign and malignant MMs, a receiver operating characteristics analysis was implemented.

Results: In total, 37/69 of the MMs were benign (53.6%) and 32/69 malignant (46.4%). Benign MMs demonstrated significantly lower MAVs than mMMs (1.59 ± 0.93 vs. 2.76 ± 1.01 m/s; p < 0.001). Selecting 2.05 m/s as a cut-off value yielded a sensitivity and specificity of 75.0% and 70.3%, respectively, in diagnosing malignant MMs (area under the curve = 0.802, 95% confidence interval 0.699-0.904).

Conclusion: ARFI elastography may represent an additional non-invasive tool for differentiating benign from malignant MMs. However, to validate the results of this study, further prospective randomized studies are required.

Keywords: ARFI elastography; mesenteric mass; mesentery; sclerosing mesenteritis; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Benign mesenteric mass. An 80-year-old male patient with a known history of type 1 autoimmune pancreatitis under immunosuppressive treatment. (A) Magnetic resonance imaging appearance of a mass-like “misty mesentery” in the right upper portion of the umbilical region (arrow) (courtesy of Prof. Dr. Mahnken, Department of Radiology, University Hospital Marburg); (B) the ultrasound appearance of an ill-defined, slightly inhomogeneous, echogenic mesenteric mass (arrows); (C) the final acoustic radiation force impulse (ARFI) report of the same mass, showing a mean ARFI velocity (MW) of 1.29 m/s. The mesenteric histology showed an IgG−4-positive sclerosing mesenteritis. Läsion 1: lesion 1; Vs (m/s): velocity in meter per second; Tiefe (cm): depth in centimeter; MW = mean value (Mittelwert); Std-Abw.: standard deviation (Standard Abweichung); IQB: interquartile range (Interquartilbereich).
Figure 2
Figure 2
Malignant mesenteric mass. A 67-year-old male patient with a known history of malignant lymphoma and suspected recurrence on staging. (A) Computed tomography showing a hypointense round mass in the left upper quadrant (arrow) (courtesy of Prof. Dr. Mahnken, Department of Radiology, University Hospital Marburg); (B) B-mode ultrasound showing a hypoechoic mesenteric mass (arrows); (C) the final acoustic radiation force impulse (ARFI) report of the same mass, showing a mean ARFI velocity (MW) of 2.72 m/s. The mesenteric histology showed a high-grade malignant lymphoma. Läsion 1: lesion 1; Vs (m/s): velocity in meter per second; Tiefe (cm): depth in centimeter; MW = mean value (Mittelwert); Std-Abw.: standard deviation (Standard Abweichung); IQB = interquartile range (Interquartilbereich).
Figure 3
Figure 3
Malignant mesenteric mass. A 76-year-old female patient with a known history of ovarian cancer and suspected recurrence on staging. (A) Computed tomography image (left) shows a hypointense mesenteric mass (arrow) (courtesy of Prof. Dr. Mahnken, Department of Radiology, University Hospital Marburg); (B) positron emission tomography–computed tomography reveals a high intensity of fluorodeoxyglucose uptake within the mass (arrow)), indicating mesenteric metastasis (courtesy of Prof. Dr. Luster, Department of Nuclear Medicine, University Hospital Marburg); (C) B-mode ultrasound showing a hypoechoic mesenteric mass; (D) the final acoustic radiation force impulse (ARFI) report of the same mass, showing a mean ARFI velocity (MW) of 4.05 m/s. Läsion 1: lesion 1; Vs (m/s): velocity in meter per second; Tiefe (cm): depth in centimeter; MW = mean value (Mittelwert); Std-Abw.: standard deviation (Standard Abweichung); IQB = interquartile range (Interquartilbereich); E: elasticity in Kilopaskal (kPa).
Figure 4
Figure 4
Differences in mean acoustic radiation force impulse (ARFI) velocities between benign and malignant mesenteric masses in the study. The mean ARFI velocity (MAV) in m/s is represented with an “X” in each box, and the median ARFI velocity in subgroups is shown as a horizontal line within each box. bMM: benign mesenteric mass (MAV = 1.59 ± 0.90 m/s), mMM: malignant mesenteric mass (MAV = 2.76 ± 1.01 m/s) (p < 0.001).
Figure 5
Figure 5
Receiver operator characteristic curve for the differences in mean acoustic radiation force impulse velocities between benign and malignant mesenteric masses.

Similar articles

Cited by

References

    1. Coffey J.C., O’Leary D.P. The mesentery: Structure, function, and role in disease. Lancet Gastroenterol. Hepatol. 2016;1:238–247. doi: 10.1016/S2468-1253(16)30026-7. - DOI - PubMed
    1. Dufay C., Abdelli A., Le Pennec V., Chiche L. Mesenteric tumors: Diagnosis and treatment. J. Visc. Surg. 2012;149:e239–e251. doi: 10.1016/j.jviscsurg.2012.05.005. - DOI - PubMed
    1. Danford C.J., Lin S.C., Wolf J.L. Sclerosing Mesenteritis. Am. J. Gastroenterol. 2019;114:867–873. doi: 10.14309/ajg.0000000000000167. - DOI - PubMed
    1. Diab R., Virarkar M., Saleh M., Elsheif S., Javadi S., Bhosale P., Faria S. Imaging spectrum of mesenteric masses. Abdom. Radiol. 2020;45:3618–3636. doi: 10.1007/s00261-020-02535-1. - DOI - PubMed
    1. Aslan S., Nural M.S. CT features of asymptomatic heterotopic pancreas in jejunal mesentery. Turk. J. Gastroenterol. 2019;30:208–210. doi: 10.5152/tjg.2018.18064. - DOI - PMC - PubMed

LinkOut - more resources